U.S. Electrical Stock News

NasdaqGM:BBNX
NasdaqGM:BBNXMedical Equipment

Assessing Beta Bionics (BBNX) Valuation After Strong Run-Up in Share Price

Beta Bionics (BBNX) stock has drawn renewed attention this week as investors digest the company's financial trajectory. Over the past month, shares are up more than 22%, which reflects optimism around recent revenue and income growth figures. See our latest analysis for Beta Bionics. It's been a standout few months for Beta Bionics, whose 29.9% seven-day share price return and 65.8% gain over the past 90 days point to rapidly building momentum. Investors seem to be betting on the company's...
NYSE:STEM
NYSE:STEMElectrical

Stem (STEM): Assessing Valuation Following Q3 Earnings Beat and Upgraded 2025 Forecast

Stem (STEM) just released its third quarter earnings, showing a sizable jump in revenue along with a dramatic narrowing of net losses compared to the same period last year. Investors are also closely eyeing the company’s updated revenue forecast for 2025. See our latest analysis for Stem. Following the upbeat quarterly results and newly adjusted revenue guidance, Stem’s stock has seen its share price surge 15.76% in a single day, partially offsetting recent volatility. Despite short-term...
NasdaqCM:MARA
NasdaqCM:MARASoftware

Is Marathon Digital’s Recent Pullback a Sign of Value After Blockchain Partnership News?

Ever wondered if MARA Holdings is actually worth its current price, or if there is untapped value waiting beneath the surface? Despite a recent dip with a 6.5% decline over the last week and 2.9% for the month, MARA Holdings has delivered a strong 13.4% return over the past year and an eye-catching 658.1% in five years. These kinds of moves often prompt a closer look. This latest volatility has investors talking, as it was triggered by industry-wide shifts in digital asset sentiment and the...
NasdaqGM:MRUS
NasdaqGM:MRUSBiotechs

Merus (MRUS) Forecasts 58.4% Revenue Growth, Ongoing Losses Challenge Bullish Narratives

Merus (MRUS) is projected to deliver standout revenue growth of 58.4% per year, far outpacing the US market average of 10.4% per year. However, the company remains unprofitable, with losses increasing at a 34.9% annual rate over the past five years and no improvement in net profit margins. Investors are watching closely, as persistent losses now set a high bar for optimism. At the same time, rapid top-line growth keeps the story in focus. See our full analysis for Merus. Next up, we will...
NasdaqCM:TALK
NasdaqCM:TALKHealthcare

Why Talkspace (TALK) Is Up 17.0% After Strong Q3 Results and Wisdo Health Acquisition

On October 30, 2025, Talkspace reported third-quarter earnings with revenue rising to US$59.38 million and net income growing to US$3.25 million, alongside a raised full-year 2025 revenue guidance and the acquisition of Wisdo Health to expand its AI-powered behavioral health services. The company also advanced its proprietary mental health-focused AI model, with an expected launch in early 2026, underscoring a push to differentiate its technology offerings and broaden its reach, especially...